| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -53,575 | -33,960 |
| Depreciation and amortization | 3,891 | 2,535 |
| Reduction in the carrying amount of right-of-use assets | 2,178 | 1,440 |
| Stock-based compensation | 7,424 | 4,911 |
| Provision (recovery) for credit losses | -113 | -113 |
| Asset impairment and other charges | 0 | 0 |
| Impairment of investment in non-marketable securities | 0 | - |
| Non-cash interest expense | 929 | 572 |
| Amortization of discount on short-term investments | -931 | -597 |
| Other non-cash items | 0 | 0 |
| Financial assets | -9,346 | -2,640 |
| Inventories | 137 | 146 |
| Prepaid expenses and other assets | 1,320 | -405 |
| Accounts payable | -493 | -1,398 |
| Accrued compensation and other accrued liabilities | 4,295 | 6,278 |
| Other long term liabilities | -2,318 | -1,526 |
| Deferred revenue | -54 | -250 |
| Net cash used in operating activities | -39,468 | -31,765 |
| Purchase of property and equipment | 3,951 | 3,769 |
| Proceeds from sale of property and equipment | 5 | 4 |
| Purchases of short-term investments | 41,891 | 24,183 |
| Proceeds from maturity of short-term investments | 63,626 | 39,350 |
| Proceeds from sale of short-term investments | 0 | - |
| Net cash provided by (used in) investing activities | 17,789 | 11,402 |
| Proceeds from exercises of stock options | 1,098 | 1,098 |
| Proceeds from issuance of stock under employee stock purchase plan | 317 | 317 |
| Proceeds from issuance of common stock in connection with equity sales agreements | 17,268 | 17,268 |
| Costs incurred in connection with equity sales agreements | 829 | 718 |
| Proceeds from long-term debt | 9,897 | 9,897 |
| Payment of debt issuance costs | 3 | 3 |
| Net cash provided by financing activities | 27,748 | 27,859 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 6,069 | 7,496 |
| Cash and cash equivalents at beginning of period | 20,829 | - |
| Cash and cash equivalents at end of period | 26,898 | - |
CODEXIS, INC. (CDXS)
CODEXIS, INC. (CDXS)